Yahoo Web Search

Search results

1. www.linkedin.com › in › michael-reilly-0a6653Michael Reilly - Executive Director, Medical Education ...

   www.linkedin.com › in › michael-reilly-0a6653

   Mar 1, 2004 · Michael Reilly - Executive Director, Medical Education - Regeneron Pharmaceuticals, Inc. | LinkedIn. Tarrytown, New York, United States. 446 followers 449 connections. View mutual connections...

   • Connections: 447
   • Followers: 446

   • Works For: Regeneron Pharmaceuticals, Inc.
   • Location: Tarrytown, NY

2. informaconnect.com › speakers › michael-reillyMichael Reilly - Regeneron Pharmaceuticals, Inc ...

   informaconnect.com › speakers › michael-reilly

   • Cached

   Michael Reilly - Regeneron Pharmaceuticals, Inc. | Independent Medical Education and Grants Summit Speaker. Book Now. Michael Reilly. Executive Director, Medical Education at Regeneron Pharmaceuticals, Inc. Speaker. Profile. Michael Reilly has been working in CME since what seems like the dawn of time.

3. www.regeneron.com › about › leadershipMeet Regeneron's Leadership Team

   www.regeneron.com › about › leadership

   • Cached

   Leonard (Len) Brooks joined Regeneron in 2013 and serves as senior vice president, treasurer. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regeneron’s cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance providers and rating agencies.

   • 
   • 
   • 
   • 

4. www.zoominfo.com › p › Michael-ReillyMichael Reilly Email & Phone Number | Executive Director ...

   www.zoominfo.com › p › Michael-Reilly

   • Cached

   Michael Reilly is an Executive Director, Medical Education at Regeneron Pharmaceuticals based in Tarrytown, New York. Previously, Michael was a Ge neral Manager at P4 Healthcare and also held positions at Merck, Oncogenetics, Collaborative Diagnostics, DIANON Systems.

   • Location: 777 Old Saw Mill River Rd, Tarrytown, 10591, New York
   • Occupation: Executive Director, Medical Education

   • Phone: (914) 847-7000
   • Works For: Regeneron Pharmaceuticals

5. www.nejm.org › doi › fullREGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients ...

   www.nejm.org › doi › full

   Dec 17, 2020 · Regeneron’s COVID-19 outpatient trial prospectively demonstrates that REGN-COV2 antibody cocktail significantly reduced virus levels and need for further medical attention.

   • Author: David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao, Rafia Bhore, Bret ...

   • Publish Year: 2021

6. www.nejm.org › doi › fullSubcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

   www.nejm.org › doi › full

   Aug 4, 2021 · VOL. 385 NO. 13. Abstract. Background. REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal antibodies casirivimab and imdevimab, has been shown to markedly reduce the...

7. www.nejm.org › doi › pdfREGEN-COV Antibody Combination and Outcomes in Outpatients ...

   www.nejm.org › doi › pdf

   at david.weinreich@regeneron.com or at Regeneron Pharmaceuticals, 777 Old Saw Mill River Rd., Tarrytown, NY 10591-6707. *A complete list of the trial investigators is provided in the Supplementary Ap-